NYSE / NASDAQ · SEC EDGAR
Equity research
Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.
Research preview · Quarterly financial statements · No price quotes · Not financial advice
Example screens
- Best combined rank222Issuers with both EPS acceleration and ROE, highest rank first.
- Profitable growth43ROE at least 15% and revenue growth at least 10%.
- Earnings acceleration376EPS acceleration at or above zero, largest first.
- High return on equity120ROE at least 25%, highest first.
- NYSE only128The same ranking with NYSE listings only.
Example lists from a senior trader
- All 47 screens9191 of 279 companies are in this screen.
- 2026 · 06-27 14023566 of 8 companies are in this screen.
- 2026 · 06-27 14000344 of 10 companies are in this screen.
- 2026 · 06-27 14012944 of 9 companies are in this screen.
- 2026 · 06-27 14014744 of 9 companies are in this screen.
- 2026 · 06-27 14015833 of 9 companies are in this screen.
- 2026 · 06-27 14022744 of 9 companies are in this screen.
- 2026 · 06-27 14031844 of 10 companies are in this screen.
- 2026 · 06-27 14081955 of 8 companies are in this screen.
| Company | Combined rank | EPS acceleration | Revenue growth | ROE | Net margin | Reporting period |
|---|---|---|---|---|---|---|
| APTVAptiv PLCNYSE | — | — | 2.3% | 2.5% | 1.2% | 2026-06-30Filed 2026-08-04 |
| APURAperture ACNASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-13 |
| APUSApimeds Pharmaceuticals US, Inc.NYSE | — | — | — | — | — | 2026-06-30Filed 2026-08-14 |
| APVOAptevo Therapeutics Inc.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-14 |
| APXTApex Treasury CorpNASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-11 |
| APYXApyx Medical CorpNASDAQ | — | — | 22.1% | — | — | 2026-06-30Filed 2026-08-06 |
| AQBAQUABOUNTY TECHNOLOGIES INCNASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-06 |
| AQMSAqua Metals, Inc.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-07-30 |
| AQSTAquestive Therapeutics, Inc.NASDAQ | — | — | 38.1% | — | — | 2026-06-30Filed 2026-08-11 |
| ARANTERO RESOURCES CorpNYSE | — | -80.6 pp | 20.2% | — | — | 2026-06-30Filed 2026-07-29 |
| ARAIArrive AI Inc.NASDAQ | — | — | -83.8% | — | — | 2026-06-30Filed 2026-08-13 |
| ARAYACCURAY INCNASDAQ | — | — | -7.4% | — | — | 2026-06-30Filed 2026-08-27 |
| ARCBARCBEST CORP /TX/NASDAQ | — | -16.9 pp | 15.9% | — | — | 2026-06-30Filed 2026-07-30 |
| ARCCARES CAPITAL CORPNASDAQ | — | 10.0 pp | — | — | — | 2026-06-30Filed 2026-07-29 |
| ARCIArchimedes Tech SPAC Partners III Co.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-13 |
| ARCLARC Group Acquisition I Corp.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-04 |
| ARCTArcturus Therapeutics Holdings Inc.NASDAQ | — | — | -89.5% | — | — | 2026-06-30Filed 2026-08-06 |
| ARDTArdent Health, Inc.NYSE | — | -73.5 pp | -1.4% | — | — | 2026-06-30Filed 2026-08-10 |
| ARDXARDELYX, INC.NASDAQ | — | — | 23.8% | — | — | 2026-06-30Filed 2026-08-06 |
| AREALEXANDRIA REAL ESTATE EQUITIES, INC.NYSE | — | — | — | — | — | 2026-06-30Filed 2026-08-03 |
| ARESAres Management CorpNYSE | — | — | 5.8% | — | — | 2026-06-30Filed 2026-08-07 |
| ARHSArhaus, Inc.NASDAQ | — | 45.3 pp | 7.4% | — | — | 2026-06-30Filed 2026-08-06 |
| ARIApollo Commercial Real Estate Finance, Inc.NYSE | — | -8.3 pp | -37.4% | — | — | 2026-06-30Filed 2026-08-10 |
| ARKOARKO Corp.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-07 |
| ARKRARK RESTAURANTS CORPNASDAQ | — | — | -6.5% | — | — | 2026-06-27Filed 2026-08-11 |
How the lists overlap
EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.
The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.
Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.
What this data covers
Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.
The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.
Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.
Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-09-18. Source: FRED / Federal Reserve.